NRIX - Nurix Therapeutics, Inc.
IEX Last Trade
19.54
-0.070 -0.358%
Share volume: 940
Last Updated: Fri 27 Dec 2024 03:30:33 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$19.61
-0.07
-0.36%
Summary score
21%
Profitability
18%
Dept financing
9%
Liquidity
68%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.68%
Return on assets
-9.8%
Return on sales
-376.32%
Return on invested capital
-9.63%
Total debt ratio
29.66%
Debt ratio change over timeo
-1.21%
Current Ratio
4.97%
Quick Ratio
4.97%
Cash Position Ratio
4.81%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.34%
Return on assets
-12.42%
Return on sales
-297.45%
Return on invested capital
178.39%
Total debt ratio
35.31%
Debt ratio change over timeo
-0.81%
Current Ratio
4.05%
Quick Ratio
4.05%
Cash Position Ratio
3.95%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-12.02%
Return on assets
-9.5%
Return on sales
-401.42%
Return on invested capital
223.12%
Total debt ratio
27.46%
Debt ratio change over time
-0.82%
Current Ratio
5.57%
Quick Ratio
5.57%
Cash Position Ratio
5.49%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-92.87%
Return on assets
-94.61%
Return on sales
267.96%
Return on invested capital
25.21%
Total debt ratio
-120.88%
Debt ratio change over time
-1.21%
Current Ratio
-6.51%
Quick Ratio
-6.51%
Cash Position Ratio
-6.32%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NRIX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.68% | 15.05% | 35.64% | 7.13% |
| Return on assets | -9.8% | 2.88% | 3.13% | 5.53% |
| Return on sales | -376.32% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -9.63% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 29.66% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.21% | 326.95% | -8.44% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 4.05% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.05% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.95% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 10% | 22% | 54% |
| Short-term ratios | NRIX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.34% | 13.14% | 10.88% | 4.07% |
| Return on assets | -12.42% | 2.1% | 1.54% | 3.03% |
| Return on sales | -297.45% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 178.39% | 1.95% | 2.74% | 9.55% |
| Profitability | 25% | 61% | 49% | 59% |
| Total debt ratio | 35.31% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -0.81% | 51.04% | -101.54% | 1.43% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 4.05% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.05% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.95% | 0.39% | 1.05% | 2.91% |
| Liquididy | 66% | 11% | 24% | 68% |